Responsibilities:
- Provide leadership, management, and development of a Data Generation book of work.
- Partner with matrix stakeholders to plan and design data generation plans (DGP), drive disciplined study execution, translate results, and disseminate findings internally and externally.
- Provide scientific leadership for real-world evidence and non-interventional study methodologies, including enabling external scientific advice and incorporating protocol review committee guidance.
- Engage external experts, clinical guideline groups, HTA agencies, and methodology/policy forums to drive innovation and enable efficient evidence development across the lifecycle.
- Integrate expertise in global HTA bodies, clinical guidelines, payer decision makers, and processes related to recommendation, reimbursement, pricing, and access.
- Lead discussions to prioritize data generation based on business and customer needs.
- Deliver materials for internal governance (e.g., Medical Review Board).
- Facilitate alignment across complex stakeholder matrices (clinical, commercial, market access, medical affairs, priority market LOCs, and external suppliers).
- Represent the company in external collaborations and evidence requirements with partners and decision makers.
- Drive quality and compliance of delivered evidence; ensure performance reporting, studies are delivered on plan and within budget.
Qualifications (Required):
- PhD, PharmD, or equivalent in health outcomes/PROs, health economics, epidemiology, pharmacy, health, or life sciences.
- 5+ years in global pharmaceuticals in a leadership role with line management experience.
- Strong business acumen; ability to translate customer needs into actionable data generation plans.
- Methods expertise for robust payer evidence deliverables and credibility with external experts.
- Knowledge of global and local healthcare markets, HTA, and reimbursement decision-making.
- Understanding of health economics/outcomes, comparative effectiveness, PRO research, and PRO instruments for local decision-making.
- Deep knowledge of drug development and therapy area.
- Strong communication, matrix leadership, and stakeholder management; ability to work independently.
- Experience across product lifecycles; senior experience leading a complex portfolio and analytics staff.
Qualifications (Preferred):
- Advanced degree specialized in health outcomes.
- Experience in above-country and in-country roles.
- Hepatology therapeutic area experience.
- Experience supporting assets in complex competitor landscapes.
- Direct payer experience.
- Launch experience.
- Portfolio of high value publications and/or scientific promotions.
#J-18808-Ljbffr
Senior Director, Global Real-World Evidence & Health Outcomes Research Lead, Specialty Medicines employer: Scorpion Therapeutics
At GSK, we are dedicated to fostering a dynamic and inclusive work environment that empowers our employees to make a real difference in patients' lives. As the Head of RTSM, you will have the opportunity to lead innovative projects in a collaborative culture that values accountability and impact, while benefiting from comprehensive growth opportunities and a robust benefits package. Join us in Upper Providence, Pennsylvania, or Stevenage, UK, where your contributions will directly influence the future of healthcare and help us achieve our ambitious goal of improving the health of 2.5 billion people by the end of the decade.
